Repeated infusions of infliximab, a chimeric anti-TNFα monoclonal antibody, in patients with active spondyloarthropathy: one year follow up

Background: In a pilot study, the anti-tumour necrosis factor α monoclonal antibody, infliximab, induced a rapid and significant improvement in global, peripheral, and axial disease manifestations of patients with active spondyloarthropathy. Objective: To determine whether repeated infusions of infl...

Full description

Saved in:
Bibliographic Details
Main Authors: Kruithof, E, Van den Bosch, F, Baeten, D, Herssens, A, De Keyser, F, Mielants, H, Veys, E
Format: Artigo
Language:Inglês
Published: 2002
Subjects:
Extended Report
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC1754032/
https://ncbi.nlm.nih.gov/pubmed/11830424
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.61.3.207
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items